Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,432 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00002932 | Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck | completed | Phase 2 | 60 | Radiation Therapy Oncology GroupNETWORK | 1 | Nov 21, 2014 | clinicaltrials |
| NCT00697905 | Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma | completed | Phase 2 | 18 | Ministry of Health, MalaysiaOTHER_GOV | 1 | Nov 21, 2014 | clinicaltrials |
| NCT01417143 | Dovitinib in Adenoid Cystic Carcinoma | completed | Phase 2 | 33 | Seoul National University HospitalOTHER | 1 | Nov 13, 2014 | clinicaltrials |
| NCT01465308 | The Effect of Honey on Xerostomia and Oral Mucositis(AC-H) | completed | Phase 2 | 72 | Cyprus University of TechnologyOTHER | 1 | Oct 8, 2014 | clinicaltrials |
| NCT00507767 | Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Oct 1, 2014 | clinicaltrials |
| NCT01305772 | Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN(TOP0901) | terminated | Phase 2 | 6 | Neal ReadyOTHER | 1 | Aug 29, 2014 | clinicaltrials |
| NCT01682031 | Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy | terminated | Phase 2 | 18 | Roswell Park Cancer InstituteOTHER | 2 | Aug 22, 2014 | clinicaltrials |
| NCT01403259 | SOX as Salvage Treatment in Nasopharyngeal Carcinoma | terminated | Phase 2 | 16 | Fudan UniversityOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT00134043 | Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer | completed | Phase 2 | 19 | National Cancer Institute (NCI)NIH | 1 | Aug 11, 2014 | clinicaltrials |
| NCT00113334 | Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer | completed | Phase 1 / Phase 2 | 6 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2014 | clinicaltrials |
| NCT00049140 | EF5 Compared With Other Methods of Detecting Oxygen Levels in Tumor Cells of Patients With Head and Neck Cancer | completed | Phase 2 | 8 | David M. Brizel, MDOTHER | 1 | Jul 25, 2014 | clinicaltrials |
| NCT00387335 | Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | completed | Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | Jul 25, 2014 | clinicaltrials |
| NCT02027831 | NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICG | unknown | Phase 2 | 10 | Jules Bordet InstituteOTHER | 1 | Jul 24, 2014 | clinicaltrials |
| NCT02187315 | Induction Chemotherapy Followed By Chrono-chemotherapy Concurrent With IMRT Of Locally Advanced NPC Clinical Study | unknown | Phase 2 | 160 | Feng JingOTHER | 1 | Jul 11, 2014 | clinicaltrials |
| NCT00002774 | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | 63 | Stanford UniversityOTHER | 1 | Jun 20, 2014 | clinicaltrials |
| NCT00141765 | Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers | completed | Phase 2 | 25 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jun 20, 2014 | clinicaltrials |
| NCT00101348 | Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 66 | National Cancer Institute (NCI)NIH | 1 | Jun 11, 2014 | clinicaltrials |
| NCT00507429 | Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer(FACT) | terminated | Phase 2 / Phase 3 | 80 | Mateon TherapeuticsINDUSTRY | 12 | Jun 9, 2014 | clinicaltrials |
| NCT00918281 | Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection | completed | Phase 2 | 70 | GE HealthcareINDUSTRY | 1 | Jun 9, 2014 | clinicaltrials |
| NCT01425736 | Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma | completed | Phase 2 | 91 | Wei GuoOTHER | 1 | Jun 3, 2014 | clinicaltrials |
| NCT00098813 | Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | May 28, 2014 | clinicaltrials |
| NCT00103259 | Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 71 | National Cancer Institute (NCI)NIH | 1 | May 23, 2014 | clinicaltrials |
| NCT00184028 | Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 2 | 12 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00492089 | Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | May 9, 2014 | clinicaltrials |
| NCT00513435 | Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 9 | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2014 | clinicaltrials |
| NCT00115739 | Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma | terminated | Phase 2 | 11 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 21, 2014 | clinicaltrials |
| NCT00148122 | A Study of a New Combination and Schedule of Chemotherapy Drugs for the Treatment of Head and Neck Cancer | completed | Phase 2 | 40 | University of Michigan Rogel Cancer CenterOTHER | 1 | Apr 17, 2014 | clinicaltrials |
| NCT02016417 | Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 120 | Cancer Hospital of Guangxi Medical UniversityOTHER | 0 | Apr 16, 2014 | clinicaltrials |
| NCT00971932 | Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | completed | Phase 2 | 33 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Apr 8, 2014 | clinicaltrials |
| NCT00589667 | A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC) | completed | Phase 2 | 26 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00959387 | Induction Chemotherapy for Advanced Head and Neck Cancer | completed | Phase 2 | 60 | Barretos Cancer HospitalOTHER | 1 | Mar 26, 2014 | clinicaltrials |
| NCT01712919 | Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC) | completed | Phase 1 / Phase 2 | 61 | Jiangsu Cancer Institute & HospitalOTHER | 1 | Mar 24, 2014 | clinicaltrials |
| NCT00865098 | Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN) | completed | Phase 2 | 27 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Mar 12, 2014 | clinicaltrials |
| NCT01417390 | Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma | unknown | Phase 2 | 80 | First People's Hospital of FoshanOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT01612286 | Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma | unknown | Phase 2 | 30 | Zhejiang Cancer HospitalOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00061906 | Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer | completed | Phase 2 | 25 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT02055989 | A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx | completed | Phase 1 / Phase 2 | 105 | Royal Marsden NHS Foundation TrustOTHER | 1 | Feb 5, 2014 | clinicaltrials |
| NCT00791141 | Adjuvant Cetuximab and Chemoradiation in Head and Neck Cancer(ACCRA-HN) | completed | Phase 2 | 80 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Jan 23, 2014 | clinicaltrials |
| NCT00203905 | A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck | completed | Phase 2 | 23 | University of ChicagoOTHER | 1 | Jan 17, 2014 | clinicaltrials |
| NCT00095693 | Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer | terminated | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Jan 16, 2014 | clinicaltrials |
| NCT00098631 | Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | completed | Phase 2 | 88 | National Cancer Institute (NCI)NIH | 1 | Jan 7, 2014 | clinicaltrials |
| NCT00004094 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx | unknown | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00098852 | Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer | unknown | Phase 2 | 25 | University of California, San FranciscoOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00003856 | Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy | unknown | Phase 2 | 75 | Quintiles, Inc.INDUSTRY | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00334997 | Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis | completed | Phase 2 | 50 | University College London HospitalsOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00022217 | Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer | unknown | Phase 2 | — | Matrix PharmaceuticalINDUSTRY | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00589186 | Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer | unknown | Phase 2 | 35 | National Cancer Centre, SingaporeOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT01865201 | Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis | completed | Phase 2 | 154 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Dec 12, 2013 | clinicaltrials |
| NCT01370876 | Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer | terminated | Phase 2 | 46 | Nang Kuang Pharmaceutical Co., Ltd.INDUSTRY | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01347424 | Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement Ultrasonography | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Dec 9, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Nov 21, 2014source: clinicaltrials